Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of ...
12d
News Medical on MSNEarly lung cancer diagnosis improved with ctDNA methylation biomarkersEarly diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...
Fluorescence navigation is a novel technique for accurately identifying hepatocellular carcinoma (HCC) lesions during hepatectomy, enabling real-time visualization. Indocyanine green-based ...
6d
MedPage Today on MSNFor Your Patients: What Is Multiple Myeloma?Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...
Healx has dosed the first patient in a Phase II trial assessing its lead pipeline candidate HLX-1502 in patients with neurofibromatosis type 1 (NF1), while the FDA approved SpringWorks Therapeutics’ ...
Results in Certain Patients With Previously Treated Advanced RCC (LITESPARK-005) The approval in adult patients with advanced clear cell RCC that progressed ... disease are at risk for recurrent, ...
Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET. Company Participants. Ray Furey - Executive Vice President, General Counsel & ...
Measurement of plasma glucose, insulin ... 1 Estimated incidence of this rare, pancreatic β-cell tumor is four in one million people per year. 2 These pancreatic lesions are often less than ...
Kyushu University researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas ...
Tumor marker blood tests serve as a powerful diagnostic tool for many types of cancer. Learn more about how healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results